ORiginal Article : Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials

논문상세정보
' ORiginal Article : Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 기초의학
  • adverse events
  • chronicconstipation
  • predictors
  • prucalopride
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
646 0

0.0%

' ORiginal Article : Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials' 의 참고문헌

  • The use of Resolor (prucalopride) for chronic constipation in women
    Woodward S Br J Nurs 21 : 982 ~ [2012]
  • The facilitating effect of prucalopride on cholinergic neurotransmission in pig gastric circular muscle is regulated by phosphodiesterase 4
    Priem E Neuropharmacology 62 : 2126 ~ 2135 [2012]
  • Symonston: Therapeutic Goods Administration
  • Summary of product characteristics
  • Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus
    Krishnamurthy S Gastroenterology 88 (1) : 26 ~ 34 [1985]
  • Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study
    Camilleri M Neurogastroenterol Motil 21 : 1256 ~ [2009]
  • Safety and adverse event profiles of oral prucalopride are similar in elderly and adult patients with chronic constipation
    Camilleri M Gastroenterology 140 (1) : S606 ~ S607 [2011]
  • Prucalopride: safety, efficacy and potential applications
    Quigley EM Therap Adv Gastroenterol 5 : 23 ~ 30 [2012]
  • Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief: results of a double-blind, placebo-controlled clinical trial
    Coremans G Digestion 67 : 82 ~ 89 [2003]
  • Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
    Ke M Neurogastroenterol Motil 24 : 999 ~ [2012]
  • Prucalopride for constipation
    Camilleri M Expert Opin Pharmacother 11 : 451 ~ 461 [2010]
  • Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
    Tack J Gut 58 : 357 ~ 365 [2009]
  • Prucalopride
    Frampton JE Drugs 69 : 2463 ~ 2476 [2009]
  • Oral prucalopride in children with functional constipation
    Winter HS J Pediatr Gastroenterol Nutr 57 : 197 ~ 203 [2013]
  • New and emerging treatment options for chronic constipation
    Schiller LR Rev Gastroenterol Disord 4 (2) : S43 ~ S51 [2004]
  • Functional bowel disorders
    Longstreth GF Gastroenterology 130 : 1480 ~ 1491 [2006]
  • Factors affecting the development of adverse drug reactions
    Alomar MJ Saudi Pharm J 22 : 83 ~ 94 [2014]
  • Epidemiology and burden of chronic constipation
    Sanchez MI Can J Gastroenterol 25 (B) : 11B ~ 15B [2011]
  • Diagnosis and treatment of chronic constipation: a European perspective
    Tack J Neurogastroenterol Motil 23 : 697 ~ 710 [2011]
  • Constipation, IBS and the 5-HT4 receptor: what role for prucalopride?
    Sanger GJ Clin Med Insights Gastroenterol 3 : 21 ~ 33 [2010]
  • Colonic mass movements in idiopathic chronic constipation
    Bassotti G Gut 29 : 1173 ~ 1179 [1988]
  • Clinical trial:the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study
    Quigley EM Aliment Pharmacol Ther 29 : 315 ~ 328 [2009]
  • Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies
    Camilleri M Aliment Pharmacol Ther 32 : 1113 ~ 1123 [2010]
  • Chronic constipation: new diagnostic and treatment approaches
    Lacy BE Therap Adv Gastroenterol 5 : 233 ~ 247 [2012]
  • Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
    Mendzelevski B Br J Clin Pharmacol 73 : 203 ~ 209 [2012]
  • A placebo-controlled trial of prucalopride for severe chronic constipation
    Camilleri M N Engl J Med 358 : 2344 ~ 2354 [2008]
  • A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation
    Müller-Lissner S Neurogastroenterol Motil 22 : 991 ~ [2010]